Company profile
AbCellera Biologics Inc. Insider Trading
ABCLEvery SEC Form 4 insider trading filing for AbCellera Biologics Inc. (ABCL) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001703057
- Filings
- 57
- Insiders
- 11
- Last filing
- 2026-08-24
Activity summary
No insider transactions in the last 30 days. The most recent was on August 24, 2026, when Michael R Hayden bought 53,613 shares. 57 filings from 11 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. AbCellera Biologics Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1.5M.
90 day insight
Over the last 90 days, AbCellera Biologics Inc. insiders bought $1.5M across 6 transactions with no open-market sales.
- Most active insider: Michael R Hayden with 3 transactions totaling $1.1M.
- Largest single purchase: $570K by Michael R Hayden on Aug 24, 2026.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Michael R Hayden | ABCL | Purchase | 53,613 | $10.64 | $570K |
| Aug 18, 2026 | John S. Montalbano | ABCL | Purchase | 10,000 | $11.03 | $110K |
| Aug 14, 2026 | Andrew Booth | ABCL | Purchase | 37,200 | $10.32 | $384K |
| Aug 12, 2026 | Michael R Hayden | ABCL | Purchase | 46,387 | $10.37 | $481K |
| Aug 11, 2026 | Michael R Hayden | ABCL | Gift | 50,000 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ABCL" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of AbCellera Biologics Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →